LYRETTE GN0602

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04 report with the FDA on 2013-11-15 for LYRETTE GN0602 manufactured by Novasys Medical.

Event Text Entries

[3960910] On (b)(4) 2013, the pt underwent a lyrette procedure under local anesthetic for stress incontinence. Twenty four (24) hours later, the pt experienced hematuria, and 1 week later the incontinence began to worsen to where she needed pads, which hadn't been necessary before. Over the following weeks the incontinence continued to worsen with several leaks a day. Further medical investigation was conducted by verathon's consulting physician in conjunction with the pt's urologist, and they both reached the following conclusion: the pt was not an ideal candidate for lyrette because of her degree of hypermobility (pop score approaching 2) and a possibly too short urethra. The lyrette procedure may have been done incorrectly (too much traction on the catheter resulting in treatment too close to the sphincter). The lyrette procedure did make the pt's incontinence worse (probably because of 1 and 2). She now has an element of isd (intrinsic sphincter deficiency) that she did not have prior to the lyrette procedure. The pt scheduled a sling procedure for (b)(6) 2013.
Patient Sequence No: 1, Text Type: D, B5


[11399936] Catheter pr0918: the catheter was discarded, and the serial number was not available from the complainant. The complete street address not provided by complainant. Result: a review of the device history records showed that the generator passed testing/inspection. Fda recall z-1404-2010, instructions for use (ifu) revision: because of complaints received by novasys of worsened stress incontinence symptoms 3-4 weeks after treatment, the instructions for use were revised to emphasize potential side effects. A field action notification letter was sent to all current customers (physicians) along with the revised instructions for use and pt information brochures. The company also updated physician information brochures and pt/physician dvds to include the information. This was shipped to physicians in (b)(4) of 2009. The letter included notice that the instructions for use had reinforced language that one of the potential side effects of the renessa system (lyrette) is worsening incontinence following treatment. It also stated that women with a urethral length shorter than 2. 5 cm should not be treated with renessa.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3022472-2013-00112
MDR Report Key3504838
Report Source04
Date Received2013-11-15
Date of Report2013-10-16
Date of Event2013-04-03
Date Mfgr Received2013-10-15
Device Manufacturer Date2007-03-01
Date Added to Maude2013-12-11
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactADAM GAINES, SR SPECIALIST
Manufacturer Street20001 NORTH CREEK PARKWAY
Manufacturer CityBOTHELL WA 98021
Manufacturer CountryUS
Manufacturer Postal98021
Manufacturer Phone4256295606
Single Use3
Remedial ActionRC
Previous Use Code3
Removal Correction NumberZ-1404-2010
Event Type3
Type of Report3

Device Details

Brand NameLYRETTE
Generic NameTRANS-URETHRAL RF SYSTEM
Product CodeNVJ
Date Received2013-11-15
Model NumberGN0602
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerNOVASYS MEDICAL
Manufacturer AddressNEWARK CA US


Patients

Patient NumberTreatmentOutcomeDate
101. Deathisabilit 2013-11-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.